An analysis of the pandemic's impacts on broader organizational and sector level dynamics in clinical research such as competitor collaboration, globalization, industry goodwill, public health, supply chain, and workplace environment....
Increased diversity in clinical trials should be a requirement, not a suggestion....
The pre-pandemic environment for clinical trials has been described as unsustainable by many observers, so the massive disruption caused by COVID-19 also presents ripe opportunities for improvement....
UW Health's Dr. Nathaniel Chin discusses the impact of lecanemab and the future of Alzheimer's and dementia-related clinical research....
The need for more diversity in clinical trials is being increasingly emphasized, but more creative and collaborative recruitment approaches may be needed to make trials more diverse....
A new report by GlobalData previews the upcoming initiations and completions of clinical trials in the new year....
Professor Paul Hutson and collaborators in the Transdisciplinary Center for Research in Psychoactive Substances study psilocybin for opioid and methamphetamine use disorders....
Retinal cells grown from stem cells can reach out and connect with neighbors, according to a new study, completing a “handshake” that may show the cells are ready for clinical trials....
Achieving clinical trial diversity will require a multi-stakeholder approach across the healthcare ecosystem, including efforts by government agencies, health systems, and industry....
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens....
